Low Bone Mass in Behaviorally HIV-Infected Young Men on Antiretroviral Therapy: Adolescent Trials Network Study 021B | Zendy

Kathleen Mulligan | Zendy; D.R. Harris | Zendy; Patricia Emmanuel | Zendy; Roger A. Fielding | Zendy; C. Worrell | Zendy; Bill G. Kapogiannis | Zendy; Dina Monte | Zendy; John W. Sleasman | Zendy; Craig M. Wilson | Zendy; Grace M. Aldrovandi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Low Bone Mass in Behaviorally HIV-Infected Young Men on Antiretroviral Therapy: Adolescent Trials Network Study 021B

Author(s) -

Kathleen Mulligan,

D.R. Harris,

Patricia Emmanuel,

Roger A. Fielding,

C. Worrell,

Bill G. Kapogiannis,

Dina Monte,

John W. Sleasman,

Craig M. Wilson,

Grace M. Aldrovandi

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis455

Subject(s) - medicine , human immunodeficiency virus (hiv) , antiretroviral therapy , young adult , bone mass , lentivirus , sida , pediatrics , viral load , immunology , viral disease , osteoporosis

Peak bone mass is achieved in adolescence/early adulthood and is the key determinant of bone mass in adulthood. We evaluated the association of bone mass with human immunodeficiency virus (HIV) infection and antiretroviral therapy (ART) during this critical period among behaviorally HIV-infected young men and seronegative controls.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research